Atlas Trials

Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Clinical trial NCT02556346 · WITHDRAWN

Trial details

NCT number
NCT02556346
Sponsor
Molecular Templates, Inc.
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic B-cell Lymphocytic LeukemiaSmall Lymphocytic Leukemia
Start date
2015-11-01
Primary completion
2016-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.